Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.

Company Outlines Strategy to Position OneTest™ as the First Affordable, Multi-Cancer Early Detection Blood Test for Earlier Stage ...

Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...

What are the benefits and challenges of using multiomics approaches to discover cancer biomarkers? Multiomics means that scientists are measuring more than one class of analyte, such as DNA, RNA, or ...

A path has now opened for early prostate cancer diagnosis through urine odor. Professor Koo Kyo-cheol of the Department of ...

In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...

Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...

Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...